besid
commonli
known
virus
caus
respiratori
tract
infect
like
respiratori
syncyti
viru
rsv
rhinovirus
adenovirus
human
coronavirus
increas
number
new
respiratori
virus
detect
last
year
virus
includ
human
metapneumoviru
hmpv
human
bocaviru
hbov
first
describ
well
human
coronavirus
respect
epidemiolog
clinic
studi
focus
children
hmpv
associ
viral
respiratori
tract
infect
unlik
hbov
relationship
hmpv
symptomat
respiratori
tract
infect
undoubt
sinc
first
descript
hbov
increas
number
preval
studi
publish
diseas
associ
children
acut
respiratori
tract
infect
remain
unclear
far
controversi
discuss
whether
human
bocaviru
inde
pathogen
rather
innoc
bystand
frequent
associ
coinfect
koch
modifi
postul
fulfil
data
adult
especi
immunocompromis
patient
limit
virus
studi
retrospect
bronchoalveolar
lavag
specimen
human
bocaviru
human
metapneumoviru
immunocompromis
adult
patient
differ
underli
diseas
atyp
pneumonia
suspect
pneumocysti
jirovecii
pneumonia
pcp
bal
specimen
examin
p
jirovecii
light
microscopi
concentr
modifi
watereeth
sediment
procedur
part
ml
suspens
use
prepar
smear
mm
smear
fix
methanol
stain
uvitex
fungiqu
r
r
kandern
germani
examin
well
magnif
zeiss
fluoresc
microscop
oberkochen
germani
previous
describ
dna
rna
extract
pcr
detect
prepar
bal
use
qiamp
tissu
kit
viral
rna
kit
qiagen
hilden
germani
respect
follow
manufactur
instruct
pcr
amplif
done
ml
reaction
mixtur
follow
condit
pmol
primer
mm
deoxynucleosid
triphosph
mm
trisehcl
ph
mm
kcl
mm
u
taq
dna
polymeras
perkineelm
norwalk
ct
usa
reaction
run
perkineelm
thermocycl
use
step
cycl
programm
initi
denatur
dna
c
min
cycl
run
c
min
anneal
temperatur
c
min
c
min
min
c
extens
cycl
primer
gtg
tac
gtt
gca
aag
tac
gat
ggc
tgt
ttc
caa
gcc
use
amplifi
basepair
dna
fragment
mitochondri
lsurrna
gene
p
jirovecii
retrospect
rsv
hmpv
coronavirus
human
bocaviru
hbov
detect
pcr
rt
pcr
previous
describ
sensit
rtpcr
reaction
rsv
hmpv
genom
equival
per
ml
determin
infect
cell
cultur
supernat
genom
equival
per
ml
clinic
sampl
human
bocaviru
determin
plasmid
dna
ml
aliquot
reaction
run
nusiev
electrophoresisgrad
agaros
gel
fmc
bioproduct
rockland
main
usa
tae
buffer
moll
tri
acet
moll
edta
ethidium
bromid
gml
visual
amplifi
pcr
product
uvillumin
procedur
avoid
contamin
strictli
follow
dnarna
isol
prepar
reaction
mixtur
amplif
analysi
physic
separ
perform
three
differ
room
posit
displac
tip
use
manipul
neg
control
contain
reaction
mixtur
without
dna
alway
done
bal
sampl
immunocompromis
patient
examin
detect
p
jirovecii
insuffici
amount
bal
sampl
patient
exclud
retrospect
laboratori
analysi
new
emerg
virus
patient
includ
analysi
patient
hivinfect
suffer
hematolog
malign
eg
leukemia
lymphoma
treat
immunosuppress
medic
solid
organ
transplant
eg
kidney
heart
multisystem
diseas
overal
p
jirovecii
detect
patient
includ
retrospect
analysi
hivinfect
patient
five
patient
hematolog
malign
four
patient
immunosuppress
treatment
due
caus
tabl
sever
bacteria
cultur
patient
fungi
found
five
patient
virus
detect
five
patient
cmv
one
patient
hematolog
malign
influenza
two
patient
one
hivinfect
patient
one
immunosuppress
medic
rsv
influenza
b
coronaviru
detect
bal
specimen
hmpv
detect
bal
specimen
male
patient
chronic
myeloid
leukemia
allogen
bone
marrow
transplant
admit
sever
dyspnea
cough
fever
atyp
pneumonia
diagnos
chest
xray
comput
tomographi
bronchoscopi
show
hyperemia
tracheal
mucosa
suggest
inflamm
histolog
analysi
lung
biopsi
result
infiltr
lymphocyt
plasma
cell
addit
diagnosi
adenocarcinoma
lung
patient
show
sepsislik
syndrom
pulmonari
hemorrhag
previous
describ
englund
cowork
unfortun
patient
die
due
sever
aggrav
atyp
pneumonia
fatal
pulmonari
failur
day
admiss
human
bocaviru
detect
bal
specimen
femal
patient
lymphoma
induc
immunosuppress
due
chemotherapi
develop
fever
unknown
origin
treat
antibiot
antimycot
treatment
ganciclovir
suspect
cmv
infect
patient
report
ongo
pneumonialik
symptom
atyp
pneumonia
diagnos
bal
specimen
taken
posit
result
hbov
within
day
symptom
improv
continu
patient
discharg
hospit
pneumocysti
pneumonia
one
lead
caus
diseas
frequent
first
sever
aid
defin
ill
hivinfect
patient
sinc
introduct
pcp
prophylaxi
initi
high
activ
antivir
therapi
haart
incid
pcp
declin
approxim
per
person
year
hivinfect
patient
despit
improv
pcp
still
common
aid
defin
opportunist
infect
northern
america
europ
pcp
also
recogn
patient
malign
solid
organ
transplant
immunosuppress
treatment
high
risk
immunocompromis
patient
underw
diagnost
procedur
includ
bal
atyp
pneumonia
diagnosi
pcp
patient
hivinfect
group
howev
examin
patient
pathogen
detect
sever
pathogen
found
newli
describ
respiratori
virus
detect
two
patient
consist
previous
publish
studi
englund
et
al
evalu
retrospect
bal
specimen
adult
patient
hematopoiet
stem
cell
transplant
presenc
hmpv
detect
five
five
patient
four
die
respiratori
complic
like
patient
median
day
contrast
none
eight
adult
patient
pneumonia
sole
detect
hmpv
sever
underli
diseas
die
recent
publish
studi
johneston
et
al
immunocompromis
patient
exclud
analysi
immunocompromis
patient
seem
appar
sever
affect
nonimmunocompromis
patient
like
observ
sever
virus
barenfang
patient
older
year
patient
younger
year
detect
hmpv
vs
notabl
also
one
children
adult
hospit
kamboj
cowork
recent
found
hmpvinfect
cancer
patient
caus
number
unspecif
respiratori
symptom
observ
fatal
case
respiratori
hmpvinfect
cohort
thu
case
describ
englund
et
al
may
suffer
addit
predispos
condit
identifi
far
howev
two
studi
describ
infect
hmpv
hematopoiet
cell
transplant
recipi
thu
inde
sever
far
neglect
case
cohort
clinic
relev
hbov
uncertain
contrast
hmpv
proport
respiratori
specimen
symptomat
hospit
children
contain
hbov
dna
rang
recent
review
group
high
rate
coinfect
viral
pathogen
suggest
viru
possibl
passeng
unpublish
prospect
matchedpair
analysi
work
group
shown
hospit
children
hbovinfect
appear
seriou
rsvinfect
data
demonstr
human
bocaviru
independ
sever
pathogen
schildgen
et
al
submit
adult
patient
import
hbov
respiratori
pathogen
unclear
recent
longtin
et
al
detect
hbov
one
symptomat
adult
bronchiti
pneumonia
howev
recent
describ
clinic
case
sever
pneumonia
like
associ
hbov
adult
patient
also
confirm
radiolog
find
hbov
immunocompromis
pediatr
patient
describ
organ
transplant
hivinfect
children
occurr
hbov
adult
immunocompromis
patient
describ
present
studi
seem
rare
prospect
studi
lack
studi
show
young
infant
affect
infect
new
respiratori
virus
eg
hmpv
hbov
viral
pathogen
care
includ
routin
test
adult
patient
atyp
pneumonia
studi
necessari
prove
clinic
relev
adult
especi
hbov
